PHG vs ZBH
Koninklijke Philips N.V. vs Zimmer Biomet — AI-powered side-by-side comparison
PHG
Koninklijke Philips N.V.
61
Buy
VS
| Metric | PHG | ZBH |
|---|
| AI Score |
61
|
69
|
| Price |
$27.06
|
$97.22
|
| P/E Ratio |
20.13×
|
23.54×
|
| ROE |
8.2%
|
5.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
45.9%
|
69.9%
|
| Debt / Equity |
0.65×
|
0.59×
|
| Dividend Yield |
3.6%
|
1.0%
|
| RSI (14) |
64.1
|
63.1
|
| Beta |
0.916
|
0.462
|
| Expected Upside |
—
|
+3.7%
|
AI Committee View
Current Innellis committee reasoning for PHG versus ZBH.
ZBH leads by 8 points.
ZBH scores 69/100 (Buy) versus PHG at 61/100 (Buy).
PHG Committee View
60% agreement
5 analysts
Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- Dividend yield of 4.2% pays you to wait — Value
- EPS growing 157.8% YoY — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Revenue declining -25.8% YoY -- this is not a growth story right now — Growth
ZBH Committee View
80% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend. The committee is constructive but not yet at full conviction.
Bull Case
- Price-to-book of 1.4x is a discount to asset value — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical